Nexus Investment Management Ulc Novartis Ag Transaction History
Nexus Investment Management Ulc
- $601 Million
- Q1 2025
A detailed history of Nexus Investment Management Ulc transactions in Novartis Ag stock. As of the latest transaction made, Nexus Investment Management Ulc holds 220 shares of NVS stock, worth $24,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220Holding current value
$24,805% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.33 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.17 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$970 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$796 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$763 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $243B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...